Phase I Trial of Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Phase of Trial: Phase I
Latest Information Update: 21 Jun 2017
At a glance
- Drugs Ribociclib (Primary) ; Carboplatin; Paclitaxel
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Adverse reactions
- 15 Jun 2017 Status changed from not yet recruiting to recruiting.
- 24 May 2017 Planned initiation date changed from 1 May 2017 to 1 Jun 2017.
- 16 Mar 2017 Planned initiation date changed from 1 Mar 2017 to 1 May 2017.